ABOUT
Our Story
Careers
Press
National Technology Alliance
Advanced Technology International
Smart Cities Connect
APPROACH
Opportunities
Case Studies
Services
Events
Briefs
CONNECT
2026 Industrial Biotech Innovation Challenge Response Form
Industrial Biotech Innovation Challenge Application
Respondent Information
First Name
*
Last Name
*
Job Title
*
Email
*
Address
*
Address
Address
Address
City
City
State/Province
State/Province
Zip/Postal
Zip/Postal
Country
Afghanistan
Aland Islands
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antarctica
Antigua and Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bonaire, Sint Eustatius and Saba
Bosnia and Herzegovina
Botswana
Bouvet Island
Brazil
British Indian Ocean Territory
Brunei
Bulgaria
Burkina Faso
Burundi
Côte d'Ivoire
Cambodia
Cameroon
Canada
Cape Verde
Cayman Islands
Central African Republic
Chad
Chile
China
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Congo
Cook Islands
Costa Rica
Croatia
Cuba
Curacao
Cyprus
Czech Republic
Denmark
Djibouti
Dominica
Dominican Republic
East Timor
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Falkland Islands (Malvinas)
Faroe Islands
Fiji
Finland
France
French Guiana
French Polynesia
French Southern Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Greece
Greenland
Grenada
Guadeloupe
Guam
Guatemala
Guernsey
Guinea
Guinea-Bissau
Guyana
Haiti
Heard Island and McDonald Islands
Holy See
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran
Iraq
Ireland
Isle of Man
Israel
Italy
Jamaica
Japan
Jersey
Jordan
Kazakhstan
Kenya
Kiribati
Kosovo
Kuwait
Kyrgyzstan
Laos
Latvia
Lebanon
Lesotho
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Macao
Macedonia
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique
Mauritania
Mauritius
Mayotte
Mexico
Micronesia
Moldova
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
New Caledonia
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
North Korea
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Palestine
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn
Poland
Portugal
Puerto Rico
Qatar
Reunion
Romania
Russia
Rwanda
Saint Barthelemy
Saint Helena, Ascension and Tristan da Cunha
Saint Kitts and Nevis
Saint Lucia
Saint Martin (French part)
Saint Pierre and Miquelon
Saint Vincent and the Grenadines
Samoa
San Marino
Sao Tome and Principe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Sint Maarten (Dutch part)
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South Georgia and the South Sandwich Islands
South Korea
South Sudan
Spain
Sri Lanka
Sudan
Suriname
Svalbard and Jan Mayen
Swaziland
Sweden
Switzerland
Syria
Taiwan
Tajikistan
Tanzania
Thailand
Timor-Leste
Togo
Tokelau
Tonga
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
Turks and Caicos Islands
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States
United States Minor Outlying Islands
Uruguay
Uzbekistan
Vanuatu
Vatican City
Venezuela
Vietnam
Virgin Islands, British
Virgin Islands, U.S.
Wallis and Futuna
Western Sahara
Yemen
Zambia
Zimbabwe
Country
Phone
*
Organization Information
Organization Name
*
Website/URL
Organization Type
*
Academic/Government Lab
Early-Stage Startup (Seed)
Mid-Stage Startup (A or B)
Commercial Startup (C+)
Small-to-Medium Enterprise
Corporation
Non-Profit
Number of Employees
*
< 19
20-99
100-499
500-2499
2500 <
Current TRL
*
1
2
3
4
5
6
7
8
9
Primary Focus of Proposed Solution
*
Cost-Competitive Bio-Based Production
Scalable Biomanufacturing and Process Innovation
Feedstocks, Inputs and Circular Conversion
Industrial Integration and Deployment Pathways
Other
Other
Industry Sub-Sector that Best Categorizes Your Solution
*
Agriculture & Food Systems
Industrial Chemicals & Materials
Energy & Carbon Systems
Environmental & Waste Systems
Healthcare & Life Sciences
Industrial Manufacturing & Process Systems
Supply Chain & Logistics Systems
Consumer & Retail Products
Cross-cutting / Platform Technologies
Biological System that Best Categorizes Your Solution
*
Cell-based systems (microbial, yeast/fungal, algae, mammalian, plant)
Cell-free/in vitro systems (protein synthesis, enzyme, etc.)
Engineered biological systems (SynBio, genome-edited, etc.)
Natural biological systems (wild-type, microbiome, etc.)
Hybrid bio–non-bio systems (bioelectrical, biochemical, physical process integration, etc.)
Digital/computationally enabled biological systems (AI/ML, in silico, etc.)
Not primarily biological (bio-inspired, hybrid, etc.)
High-Level Technology Summary
*
0
of 100 max words
Provide a concise overview of your technology, what it does, and the problem it addresses. Focus on clarity over technical depth.
Technical Performance and Operating Characteristics
*
0
of 250 max words
Describe how the technology performs in practice, including key operating parameters, outputs, constraints, and any relevant performance metrics.
Key Innovations and Differentiation
*
0
of 200 max words
Explain what is novel or meaningfully improved compared to existing approaches. What makes this technology distinct or technically superior?
Comparison to Existing Alternatives
*
0
of 200 max words
Describe current incumbent technologies, products, or processes and how your solution compares in terms of performance, cost, scalability, or other relevant factors.
Cost and Performance Advantages
*
0
of 200 max words
Detail any measurable cost savings, efficiency gains, throughput improvements, or other economic or operational advantages relative to alternatives.
Deployment Environment
*
0
of 200 max words
Describe the real-world setting(s) where this technology is intended to operate, including physical, industrial, regulatory, or operational conditions required for use.
Validation Status and Evidence
*
0
of 200 max words
Summarize what has been demonstrated to date (e.g., lab results, pilot studies, field deployments, customer validation) and the scale at which it has been tested.
Pathway to Commercial Deployment
*
0
of 250 max words
Describe the remaining technical, regulatory, manufacturing, or operational steps required to reach commercial readiness and widespread deployment.
Scaling Strategy
*
0
of 200 max words
Explain how the technology will be scaled from its current state to broader deployment, including manufacturing, distribution, or implementation considerations.
End Users, Markets, and Use Cases
*
0
of 200 max words
Identify the primary end users and target markets, and describe key applications or use cases where the technology will be deployed.
Key Risks and Mitigation Strategies
*
0
of 200 max words
What are the key technical, regulatory, manufacturing, supply chain, or adoption risks to deployment, and how are you addressing them?
Funding and Runway
*
0
of 200 max words
Summarize funding specific to this technology, including government and private investment, as well as the current operational runway supporting continued development.
Are you currently raising capital?
*
Yes
No
Are you a traditional defense contractor?
*
Yes
No
A traditional defense contractor has done business with the federal government within the last year.
If you have a current pitch deck, share it here.
Drop a file here or click to upload
Choose File
Maximum file size: 2.1MB
If you have letters of support related to this technology, share them here.
Drop a file here or click to upload
Choose File
Maximum file size: 2.1MB
Are you interested in joining National Technology Alliance at no cost to receive funding opportunity announcements?
*
Yes
No
www.nta.org
Confirmation: I confirm that all information I have provided in this form is non-confidential, and I understand that including confidential information may result in the disqualification of this submission.
*
Submit
If you are human, leave this field blank.